AI for Medical Writing_CSR Pilot
by ALPHALIFE SCIENCES SGP PTE. LIMITED
Generative AI-Powered End-to-End Medical Writing Automation for Clinical Study Reports
Accelerating clinical development with Generative AI: Fully Automating Medical Writing with Quality Assurance. The AI-Powered Clinical Study Report Authoring product streamlines CSR creation with automation, improved quality, and Word add-in integration, accelerating development and reducing manual effort.
- 90% CSR First Draft time reduction:
- 45% Entire CSR Writing time reduction
Key Highlights
1. Accuracy Automation: GenAI-powered Clinical Study Report writing with built-in quality control.
2. Flexible Template Setup: Easily configure templates for various documents and TAs, no coding needed.Auto-generates CSR by integrating upstream data and documents, using GenAI to auto-generate both data and non-data sections. Providing organizations a flexible, no-code way to adjust generated results GenAI-powered CSR writing with built-in quality control mechanism
- Flexible templates for CSR writing can be self-configured in 2 days with no coding required.
- Effortlessly create templates by extracting from CSR samples
- Seamless integration of document systems to streamline end-to-end CSR creation
- Automatically pre-processes and generates CSR content when data updates
GenAI-Powered Automation Features
- Auto-populates SAP and Protocol content into data-independent sections.
- Auto-inserts TFLs, keeping them synchronized with their source files.
- Auto-generates TFL summaries and maintain synchronization with TFL data.
- Auto-checks quality: GenAI-Powered CSR Writing with Built-in Quality Control Mechanism.
AlphaLife Sciences, a leader in GenAI-driven clinical development, advances automated medical writing and regulatory documentation through its AuroraPrime platform, enhancing efficiency across therapeutic areas. Supported by the Microsoft for Startups Pegasus Program, Google for Startups, Nvidia Inception Program, and Johnson & Johnson Innovation JLABS, AlphaLife Sciences accelerates drug R&D and regulatory submissions, expediting life-saving treatments worldwide.